Profiles of BCL-6 and Syn-1 Expression in HD Categories
| Histology . | Patients (n =) . | Phenotype* . | ||
|---|---|---|---|---|
| BCL-6+/syn-1− . | BCL-6−/syn-1+ . | BCL-6+/syn-1− + BCL-6−/syn-1+ . | ||
| NLPHD | 10 | 10 | 0 | 0 |
| CHD | 43 | 0 | 25 | 18 |
| MC HD | 12 | 0 | 8 | 4 |
| NS HD | 31 | 0 | 17 | 14 |
| Histology . | Patients (n =) . | Phenotype* . | ||
|---|---|---|---|---|
| BCL-6+/syn-1− . | BCL-6−/syn-1+ . | BCL-6+/syn-1− + BCL-6−/syn-1+ . | ||
| NLPHD | 10 | 10 | 0 | 0 |
| CHD | 43 | 0 | 25 | 18 |
| MC HD | 12 | 0 | 8 | 4 |
| NS HD | 31 | 0 | 17 | 14 |
Abbreviations: MC, mixed cellularity; NS, nodular sclerosis.
None of the HD cases tested displayed BCL-6−/syn-1− phenotype only.